The future of pharmacogenetics for osteoporosis

Author： Marini Francesca Brandi Maria Luisa

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.14, Iss.6, 2013-04, pp. : 641-653

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pharmacogenetics and the Future of Clinical Pharmacy Practice

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 38, Iss. 1, 2008-03 ,pp. : 7-8

John Wiley & Sons Inc

Access to resources Recommend Favorite

Management of Osteoporosis: Seeing the Future

Medicinal Chemistry Reviews - Online, Vol. 1, Iss. 4, 2004-10 ,pp. : 493-500

Bentham Science Publishers

Access to resources Recommend Favorite

Future Developments in Osteoporosis Therapy

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 9, Iss. 4, 2009-01 ,pp. : 371-384

Bentham Science Publishers

Access to resources Recommend Favorite

Osteoporosis in Anorexia Nervosa: A Brittle Future

Current Drug Targets-CNS & Neurological Disorders, Vol. 2, Iss. 1, 2003-02 ,pp. : 11-15

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics and the serotonin system: initial studies and future directions

By Veenstra-VanderWeele J. Anderson G.M. Cook E.H.

European Journal of Pharmacology, Vol. 410, Iss. 2, 2000-12 ,pp. : 165-181

Elsevier

Access to resources Recommend Favorite